Comparison of Newer-Generation Drug-Eluting With Bare-Metal Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction-Reference-Cited by-同舟云学术

Comparison of Newer-Generation Drug-Eluting With Bare-Metal Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction

Published:2014-01 Issue:1 Volume:7 Page:55-63
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Sabaté Manel,Räber Lorenz,Heg Dik,Brugaletta Salvatore,Kelbaek Henning,Cequier Angel,Ostojic Miodrag,Iñiguez Andrés,Tüller David,Serra Antonio,Baumbach Andreas,von Birgelen Clemens,Hernandez-Antolin Rosana,Roffi Marco,Mainar Vicente,Valgimigli Marco,Serruys Patrick W.,Jüni Peter,Windecker Stephan

Funder

Biosensors, Biotronik, Abbott Vascular, and Terumo

Abbott Vascular, Biotronik, Boston Scientific, and Medtronic

Abbott Vascular, Boston Scientific, Biosensor, and Medtronic;

Abbott Vascular, Biosensors, Medtronic, and St. Jude Medical

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction;Stone;N Engl J Med,2009

2. Sirolimus-eluting versus uncoated stents in acute myocardial infarction;Spaulding;N Engl J Med,2006